Grace Therapeutics, Inc. (GRCE)
3.34
+0.10
(+3.09%)
USD |
NASDAQ |
Dec 16, 16:00
3.36
+0.02
(+0.60%)
After-Hours: 20:00
Grace Therapeutics Market Cap: 51.68M for Dec. 16, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 398.19M |
| Palatin Technologies, Inc. | 23.90M |
| Theriva Biologics, Inc. | 6.977M |
| Oragenics, Inc. | 0.6797M |
| NanoViricides, Inc. | 23.22M |
Market Cap Related Metrics
| Price to Book Value | 0.8227 |
| Price | 3.34 |
| Earnings Yield | -17.51% |